![](/img/cover-not-exists.png)
Metabolic Risk with Second-Generation Antipsychotic Treatment: A Double-Blind Randomized 8-Week Trial of Risperidone and Olanzapine
Kelly, Deanna L., Conley, Robert R., Love, Raymond C., Morrison, John A., Mcmahon, Robert P.Volume:
20
Language:
english
Journal:
Annals of Clinical Psychiatry
DOI:
10.1080/10401230802017050
Date:
May, 2008
File:
PDF, 125 KB
english, 2008